Michael P. Pritchard

973 total citations
18 papers, 812 citations indexed

About

Michael P. Pritchard is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Michael P. Pritchard has authored 18 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Michael P. Pritchard's work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (6 papers) and Alcohol Consumption and Health Effects (3 papers). Michael P. Pritchard is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (6 papers) and Alcohol Consumption and Health Effects (3 papers). Michael P. Pritchard collaborates with scholars based in United Kingdom, United States and France. Michael P. Pritchard's co-authors include Thomas Friedberg, C. Roland Wolf, Brian Burchell, Sylvie Fournel‐Gigleux, Gérard Siest, Jacques Magdalou, Albrecht Seidel, Lesley A. McLaughlin, Peter I. Mackenzie and Colin J. Henderson and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemistry and Analytical Biochemistry.

In The Last Decade

Michael P. Pritchard

18 papers receiving 789 citations

Peers

Countries citing papers authored by Michael P. Pritchard

Since Specialization

Citations

This map shows the geographic impact of Michael P. Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Pritchard more than expected).

Fields of papers citing papers by Michael P. Pritchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Pritchard. The network helps show where Michael P. Pritchard may publish in the future.

Co-authorship network of co-authors of Michael P. Pritchard

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Pritchard. A scholar is included among the top collaborators of Michael P. Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Pritchard. Michael P. Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Comparing characteristics of individuals screened for lung cancer with 2021 vs 2013 US Preventive Services Task Force recommendations 2024 ·JNCI Journal of the National Cancer Institute ·Louise M. Henderson, Danielle D. Durham, James F. Gruden, Michael P. Pritchard, Lindsay Lane, Jason M. Long, Christina Bellinger, M. Patricia Rivera	2
2	Establishment of Functional Human Cytochrome P450 Monooxygenase Systems in <i>Escherichia coli</i> 2006 ·Humana Press eBooks ·Michael P. Pritchard, Lesley A. McLaughlin, Thomas Friedberg	47
3	Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol 2000 ·Pharmacogenetics ·(unknown), Albrecht Seidel, Michael P. Pritchard, C. Roland Wolf, Thomas Friedberg	130
4	Amino Acid 305 Determines Catalytic Center Accessibility in CYP3A4 2000 ·Biochemistry ·Stephen Fowler, Robert J. Riley, Michael P. Pritchard, Michael J. Sutcliffe, Thomas Friedberg, C. Roland Wolf	34
5	Mechanism-Based Inactivation of Cytochrome P450 3A4 by L-754,394 2000 ·Biochemistry ·(unknown), Jeffrey P. Jones, Thomas Friedberg, Michael P. Pritchard, Magang Shou, Thomas H. Rushmore, William Trager	31
6	MERITS AND LIMITATIONS OF RECOMBINANT MODELS FOR THE STUDY OF HUMAN P450-MEDIATED DRUG METABOLISM AND TOXICITY: AN INTRALABORATORY COMPARISON 1999 ·Drug Metabolism Reviews ·Thomas Friedberg, Michael P. Pritchard, M. Bandera, (unknown), Denggao Yao, Lesley A. McLaughlin, Shaohong Ding, Brian Burchell, C. Roland Wolf	30
7	Competition Between Cytochrome P-450 Isozymes for NADPH-Cytochrome P-450 Oxidoreductase Affects Drug Metabolism 1999 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Michael P. Pritchard, Steven P. Hanlon, Brian Burchell, C. Roland Wolf, Thomas Friedberg	30
8	Electrospray Ionization Mass Spectrometric Analysis of Intact Cytochrome P450: Identification of Tienilic Acid Adducts to P450 2C9 1999 ·Biochemistry ·(unknown), Raimund M. Peter, Ann Hunter, Robert L. Haining, Allan E. Rettie, Thomas Friedberg, Michael P. Pritchard, Magang Shou, Thomas H. Rushmore, William Trager	60
9	Functional co-expression of CYP2D6 and human NADPHcytochrome P450 reductase in Escherichia coli 1998 ·Research Explorer (The University of Manchester) ·Michael P. Pritchard, (unknown), (unknown), David E. Gilham, Brian Burchell, C. Roland Wolf, Thomas Friedberg	73
10	Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity 1998 ·Biochemical Journal ·Gillian Smith, Sandeep Modi, (unknown), Lu‐Yun Lian, Michael J. Sutcliffe, Michael P. Pritchard, Thomas Friedberg, Gordon C. K. Roberts, C. Roland Wolf	46
11	A General Strategy for the Expression of Recombinant Human Cytochrome P450s inEscherichia coliUsing Bacterial Signal Peptides: Expression of CYP3A4, CYP2A6, and CYP2E1 1997 ·Archives of Biochemistry and Biophysics ·Michael P. Pritchard, (unknown), (unknown), Colin J. Henderson, Brian Burchell, C. Roland Wolf, Thomas Friedberg	103
12	Heterologous expression of human drug-metabolizing enzymes. 1997 ·PubMed ·F.Peter Guengerich, (unknown), Eric F. Johnson, (unknown), Claes von Wachenfeldt, José Cosme, Frank Jung, Christian P. Strassburg, M.P. Manns, R H Tukey, Michael P. Pritchard, Sylvie Fournel‐Gigleux, Brian Burchell	43
13	Chemical Modification of Human UDP-Glucuronosyltransferase UGT16 by Diethyl Pyrocarbonate: Possible Involvement of a Histidine Residue in the Catalytic Process 1994 ·Archives of Biochemistry and Biophysics* ·Eric Battaglia, Michael P. Pritchard, Mohamed Ouzzine, Sylvie Fournel‐Gigleux, A Radominska, Gérard Siest, Jacques Magdalou	44
14	A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. 1994 ·Molecular Pharmacology ·Michael P. Pritchard, Sylvie Fournel‐Gigleux, Gérard Siest, Peter I. Mackenzie, Jacques Magdalou	91
15	Peroxisome proliferators as inducers and substrates of UDP‐glucuronosyltransferases 1993 ·Biology of the Cell ·Jacques Magdalou, Sylvie Fournel‐Gigleux, Michael P. Pritchard, Gérard Siest	7
16	A Method for the Determination of UDP-Glucuronosyltransferase Activity toward Arylcarboxylic Acids 1993 ·Analytical Biochemistry ·Michael P. Pritchard, Sylvie Fournel‐Gigleux, Gérard Siest, Jacques Magdalou	11
17	In vitro irreversible binding of ketoprofen glucuronide to plasma proteins. 1993 ·Drug Metabolism and Disposition ·Nathalie Dubois, F. Lapicque, (unknown), Michael P. Pritchard, Sylvie Fournel‐Gigleux, Jacques Magdalou, (unknown), Gérard Siest, P. Netter	29
18	Substrate-specific glucuronidation in rat hepatocytes 1990 ·Biochemical Society Transactions ·Michael P. Pritchard, Gabrielle Hawksworth	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact